Literature DB >> 23860694

A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection.

Bahadir Ceylan1, Bilgül Mete, Muzaffer Fincanci, Turan Aslan, Yasemin Akkoyunlu, Nail Ozguneş, Onur Colak, Alper Gunduz, Ebubekir Senates, Resat Ozaras, Ayşe Inci, Fehmi Tabak.   

Abstract

BACKGROUND: We aimed to investigate whether mean platelet volume (MPV) and platelet distribution width (PDW) are variables determining the severity of liver fibrosis in patients with chronic HBV infection.
METHODS: Patients were divided into two groups with fibrosis scores of 0-2 and 3-6 (according to Ishac scoring system). Whether MPV and PDW were independent variables determining the severity of liver fibrosis score or not was investigated by comparing these groups.
RESULTS: Of the 111 cases, 74 (66.7 %) were male (mean age 37.7 ± 11.6 years). Twenty-two of the cases (19.8 %) were HBeAg-positive. Fibrosis scores of 42 cases (37.8 %) were ≥ 3 and the remaining 69 cases had fibrosis scores < 3 (62.2 %). Independent variables determining the severity of fibrosis score were low levels of albumin and mean platelet volume, and high levels of prothrombin time and PDW (Odds ratio (95 % confidence interval) and p values were 0.105 (0.018-0.605) and 0.012 for albumin, 0.402 (0.234-0.692) and 0.001 for mean platelet volume, 1.529 (1.183-1.975) and 0.001 for PDW, and 0.924 (0.875-0.976) and 0.005 for prothrombin time, respectively). The sensitivity, specificity, positive predictive value and negative predictive value of regression model that is established using above mentioned parameters were 88.1, 75.3, 68.5, and 91.7 %, respectively (AUC = 0.886, p = 0.0001).
CONCLUSIONS: MPV and PDW are independent variables determining the severity of liver fibrosis, and the regression model that is established using these parameters along with other markers, may give more information about the severity of liver fibrosis.

Entities:  

Mesh:

Year:  2013        PMID: 23860694     DOI: 10.1007/s00508-013-0394-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  27 in total

1.  Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection.

Authors:  H Schmilovitz-Weiss; A Tovar; M Halpern; J Sulkes; M Braun; Y Rotman; R Tur-Kaspa; Z Ben-Ari
Journal:  J Viral Hepat       Date:  2006-10       Impact factor: 3.728

2.  Increased mean platelet volume in chronic hepatitis B patients with inactive disease.

Authors:  Ozge Turhan; Erkan Coban; Dilara Inan; Ata Nevzat Yalcin
Journal:  Med Sci Monit       Date:  2010-04

Review 3.  Natural history of chronic hepatitis B and C.

Authors:  J C Imperial
Journal:  J Gastroenterol Hepatol       Date:  1999-05       Impact factor: 4.029

4.  Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.

Authors:  T Kawasaki; A Takeshita; K Souda; Y Kobayashi; M Kikuyama; F Suzuki; F Kageyama; Y Sasada; E Shimizu; G Murohisa; S Koide; T Yoshimi; H Nakamura; R Ohno
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

5.  Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Authors:  Leon A Adams; Max Bulsara; Enrico Rossi; Bastiaan DeBoer; David Speers; Jacob George; James Kench; Geoffrey Farrell; Geoffrey W McCaughan; Gary P Jeffrey
Journal:  Clin Chem       Date:  2005-07-28       Impact factor: 8.327

6.  Non-invasive models for predicting histology in patients with chronic hepatitis B.

Authors:  Chun-Tao Wai; Chee Leong Cheng; Aileen Wee; Yock-Young Dan; Edwin Chan; Winnie Chua; Belinda Mak; Aung Myat Oo; Seng Gee Lim
Journal:  Liver Int       Date:  2006-08       Impact factor: 5.828

7.  Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C.

Authors:  Reiichiro Kondo; Hirohisa Yano; Osamu Nakashima; Ken Tanikawa; Yoriko Nomura; Masayoshi Kage
Journal:  J Gastroenterol       Date:  2012-08-22       Impact factor: 7.527

8.  [The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B].

Authors:  Wei-Ping Liu; De-Jun Xu; Lian-Rong Zhao; Zhong-Hua Lu; Yu-Hua Wang; Zhen-Wei Lang; Gui-Qiang Wang
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2008-04

9.  Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.

Authors:  Beom Kyung Kim; Sung Ae Kim; Young Nyun Park; Jae Youn Cheong; Hwa Sook Kim; Jun Yong Park; Sung Won Cho; Kwang-Hyub Han; Chae Yoon Chon; Young Myoung Moon; Sang Hoon Ahn
Journal:  Liver Int       Date:  2007-09       Impact factor: 5.828

10.  Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis.

Authors:  Tugrul Purnak; Sehmus Olmez; Serkan Torun; Cumali Efe; Abdurrahim Sayilir; Ersan Ozaslan; Ilyas Tenlik; Ismail Hakki Kalkan; Yavuz Beyazit; Osman Yuksel
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-05-07       Impact factor: 2.947

View more
  10 in total

1.  Mean platelet volume may be confused in many conditions.

Authors:  Sevket Balta; Ugur Kucuk; Zekeriya Arslan; Murat Unlu; Sait Demirkol
Journal:  Wien Klin Wochenschr       Date:  2013-12-14       Impact factor: 1.704

2.  Can mean platelet volume be a novel predictive marker in patients with pelvic inflammatory disease?

Authors:  Ergenekon Karagöz
Journal:  Wien Klin Wochenschr       Date:  2014-09-13       Impact factor: 1.704

3.  Mean platelet volume and red blood cell distribution width in prognosis of chronic hepatitis B.

Authors:  Ergenekon Karagöz; Asım Ulçay; Vedat Turhan
Journal:  Wien Klin Wochenschr       Date:  2014-01-18       Impact factor: 1.704

4.  Mean platelet volume: a novel diagnostic factor of systemic lupus erythematosus?

Authors:  Ergenekon Karagöz; Alpaslan Tanoglu; Veysel Ozalper
Journal:  Clin Rheumatol       Date:  2014-03-28       Impact factor: 2.980

5.  Evaluation of mean platelet volume in patients with hepatitis B virus infection.

Authors:  Ying Hu; Yufeng Lou; Yuemei Chen; Weilin Mao
Journal:  Int J Clin Exp Med       Date:  2014-11-15

6.  Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.

Authors:  Dilek Yıldız Sevgi; Banu Bayraktar; Alper Gündüz; Banu Yılmaz Özgüven; Alper Togay; Emin Bulut; Nuray Uzun; İlyas Dökmetaş
Journal:  Wien Klin Wochenschr       Date:  2015-11-06       Impact factor: 1.704

7.  The effect of standard therapy on mean platelet volume in patients with chronic hepatitis C.

Authors:  Ali Ugur Uslu; Bahattin Aydin; Sevket Balta; Ozlem Yonem; Tunahan Uncu; Dogan Seven
Journal:  Prz Gastroenterol       Date:  2016-02-16

8.  Relationship between platelet parameters and hepatic pathology in patients with chronic hepatitis B infection - a retrospective cohort study of 677 patients.

Authors:  Ye Pan; Aikeremujiang Muheremu; Xiaolu Wu; Jiajun Liu
Journal:  J Int Med Res       Date:  2016-06-21       Impact factor: 1.671

9.  The Relationship between Inflammatory Marker Levels and Hepatitis C Virus Severity.

Authors:  Qitian He; Quan He; Xue Qin; Shan Li; Taijie Li; Li Xie; Yan Deng; Yu He; Yongbin Chen; Zhifu Wei
Journal:  Gastroenterol Res Pract       Date:  2016-12-20       Impact factor: 2.260

Review 10.  The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Qing Pang; Kai Qu; Jing-Yao Zhang; Si-Dong Song; Su-Shun Liu; Ming-Hui Tai; Hao-Chen Liu; Chang Liu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.